Participants on lower-to-moderate doses experienced 812% body weight loss, translating to roughly 1525 pounds for a 180-pound individualmeaning a 10-pound goal falls well within demonstrated safety and efficacy ranges
Additional known effects include cholelithiasis (related to rapid weight loss), a modest heart rate increase of 2-4 bpm, and a boxed warning for thyroid C-cell tumors based on rodent data
Missed-dose instructions depend on how much time has passed and the current product guidance
Moreover, GLP-1RAs also modestly increased heart rate, although the exact mechanisms are still unclear
Brand-level negotiations vary by budget silo, with Ozempic reimbursed under diabetes spend and Wegovy under obesity or preventive care, granting the innovator flexibility to shift promotional focus
The staff is awesome and helpful